Kodiak Sciences (KOD) Competitors $3.96 +0.13 (+3.39%) Closing price 07/3/2025 03:35 PM EasternExtended Trading$3.89 -0.07 (-1.87%) As of 07/3/2025 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KOD vs. AVXL, SION, QURE, AVBP, CRON, XERS, PHAR, REPL, VIR, and GYREShould you be buying Kodiak Sciences stock or one of its competitors? The main competitors of Kodiak Sciences include Anavex Life Sciences (AVXL), Sionna Therapeutics (SION), uniQure (QURE), ArriVent BioPharma (AVBP), Cronos Group (CRON), Xeris Biopharma (XERS), Pharming Group (PHAR), Replimune Group (REPL), Vir Biotechnology (VIR), and Gyre Therapeutics (GYRE). These companies are all part of the "pharmaceutical products" industry. Kodiak Sciences vs. Its Competitors Anavex Life Sciences Sionna Therapeutics uniQure ArriVent BioPharma Cronos Group Xeris Biopharma Pharming Group Replimune Group Vir Biotechnology Gyre Therapeutics Kodiak Sciences (NASDAQ:KOD) and Anavex Life Sciences (NASDAQ:AVXL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability. Does the media refer more to KOD or AVXL? In the previous week, Anavex Life Sciences had 3 more articles in the media than Kodiak Sciences. MarketBeat recorded 4 mentions for Anavex Life Sciences and 1 mentions for Kodiak Sciences. Anavex Life Sciences' average media sentiment score of 0.60 beat Kodiak Sciences' score of 0.00 indicating that Anavex Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kodiak Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Anavex Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is KOD or AVXL more profitable? Anavex Life Sciences' return on equity of -40.93% beat Kodiak Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Kodiak SciencesN/A -115.71% -54.17% Anavex Life Sciences N/A -40.93%-36.38% Which has higher earnings & valuation, KOD or AVXL? Anavex Life Sciences is trading at a lower price-to-earnings ratio than Kodiak Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKodiak SciencesN/AN/A-$176.21M-$3.63-1.09Anavex Life SciencesN/AN/A-$43M-$0.55-19.49 Do analysts prefer KOD or AVXL? Kodiak Sciences currently has a consensus price target of $9.00, suggesting a potential upside of 127.27%. Anavex Life Sciences has a consensus price target of $44.00, suggesting a potential upside of 310.45%. Given Anavex Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Anavex Life Sciences is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kodiak Sciences 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Anavex Life Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more risk & volatility, KOD or AVXL? Kodiak Sciences has a beta of 2.28, suggesting that its share price is 128% more volatile than the S&P 500. Comparatively, Anavex Life Sciences has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Do institutionals & insiders hold more shares of KOD or AVXL? 89.1% of Kodiak Sciences shares are held by institutional investors. Comparatively, 31.6% of Anavex Life Sciences shares are held by institutional investors. 45.9% of Kodiak Sciences shares are held by company insiders. Comparatively, 11.4% of Anavex Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryAnavex Life Sciences beats Kodiak Sciences on 10 of the 14 factors compared between the two stocks. Get Kodiak Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KOD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOD vs. The Competition Export to ExcelMetricKodiak SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$208.93M$2.89B$5.49B$9.01BDividend YieldN/A2.43%5.38%4.09%P/E Ratio-1.0921.5627.4220.26Price / SalesN/A245.52407.97121.21Price / CashN/A41.9536.6357.47Price / Book1.387.518.085.67Net Income-$176.21M-$55.05M$3.16B$248.47M7 Day Performance7.03%4.59%2.81%3.29%1 Month Performance-0.25%4.86%3.68%5.19%1 Year Performance80.00%5.82%35.29%21.35% Kodiak Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KODKodiak Sciences4.1612 of 5 stars$3.96+3.4%$9.00+127.3%+80.0%$208.93MN/A-1.0990Positive NewsAVXLAnavex Life Sciences3.6336 of 5 stars$9.22-2.7%$44.00+377.2%+160.2%$787.13MN/A-16.7640Positive NewsSIONSionna TherapeuticsN/A$17.35+9.5%$38.50+121.9%N/A$765.48MN/A0.0035Positive NewsInsider TradeQUREuniQure2.0001 of 5 stars$13.94+0.6%$37.82+171.3%+270.5%$763.63M$27.12M-3.18500News CoverageAVBPArriVent BioPharma1.7739 of 5 stars$21.77-5.0%$40.00+83.7%+13.6%$744.75MN/A-5.7740CRONCronos Group2.3339 of 5 stars$1.91+0.5%N/A-12.1%$736.65M$117.61M14.69450News CoverageXERSXeris Biopharma3.9172 of 5 stars$4.67-0.6%$6.25+33.8%+128.6%$730.30M$203.07M-15.57290Positive NewsPHARPharming Group2.4007 of 5 stars$10.68-2.9%$30.00+181.0%+23.1%$726.29M$297.20M-53.38280Positive NewsGap DownHigh Trading VolumeREPLReplimune Group4.0925 of 5 stars$9.29-0.4%$20.83+124.3%+16.8%$716.17MN/A-3.03210News CoverageAnalyst ForecastVIRVir Biotechnology3.3826 of 5 stars$5.04-2.5%$32.86+551.9%-37.3%$696.73M$74.21M-1.19580News CoveragePositive NewsInsider TradeGYREGyre Therapeutics0.0832 of 5 stars$7.35-0.9%N/A-30.5%$689.14M$105.76M367.6840 Related Companies and Tools Related Companies AVXL Competitors SION Competitors QURE Competitors AVBP Competitors CRON Competitors XERS Competitors PHAR Competitors REPL Competitors VIR Competitors GYRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KOD) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kodiak Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kodiak Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KOD Stock Alerts